Pharmacokinetics, Subjective Effects, and Abuse Liability of Nicotine Salt-Based Vaping Products With Tobacco or Unflavored E-liquids, SALTVAPE Study

NCT04231539 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Nicotine Dependence

Interventions

DRUG: Nicotine
DEVICE: Vaporizer Device
DRUG: Salt-HIgh Nicotine Unflavored (Product B)
DRUG: Free-Low Nicotine Tobacco Flavored (Product C)
DRUG: Salt-High Nicotine Tobacco Flavored (Product D)

Sponsor

Roswell Park Cancer Institute

Collaborators

[object Object]